AAAAAA

   
Results: 1-24 |
Results: 24

Authors: Chen, YM Tsai, CM Whang-Peng, J Perng, RP
Citation: Ym. Chen et al., Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions, J INTERF CY, 21(4), 2001, pp. 249-256

Authors: Su, WJ Huang, CY Huang, CY Perng, RP
Citation: Wj. Su et al., Utility of PCR assays for rapid diagnosis of BCG infection in children, INT J TUBE, 5(4), 2001, pp. 380-384

Authors: Chang, CF Su, WJ Chou, TY Perng, RP
Citation: Cf. Chang et al., Hepatocellular carcinoma with Pancoast's syndrome as an initial symptom: acase report, JPN J CLIN, 31(3), 2001, pp. 119-121

Authors: Chen, YM Tsai, CM Perng, RP
Citation: Ym. Chen et al., Reversible hepatic coma possibly induced by docetaxel treatment, LUNG CANC, 31(2-3), 2001, pp. 347-348

Authors: Chen, YM Yang, WK Whang-Peng, J Tsai, CM Perng, RP
Citation: Ym. Chen et al., An analysis of cytokine status in the serum and effusions of patients withtuberculous and lung cancer, LUNG CANC, 31(1), 2001, pp. 25-30

Authors: Wang, GS Yang, KY Perng, RP
Citation: Gs. Wang et al., Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere), BR J CANC, 85(9), 2001, pp. 1247-1250

Authors: Chen, YM Ting, CC Peng, JW Yang, WK Yang, KY Tsai, CM Perng, RP
Citation: Ym. Chen et al., Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: Interleukin-15 vs. interleukin-2, J INTERF CY, 20(1), 2000, pp. 31-39

Authors: Lai, SL Perng, RP Hwang, JL
Citation: Sl. Lai et al., p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells, J BIOMED SC, 7(1), 2000, pp. 64-70

Authors: Chen, YM Shih, JF Yang, KY Lee, YC Perng, RP
Citation: Ym. Chen et al., Usefulness of pig-tail catheter for palliative drainage of malignant pleural effusions in cancer patients, SUPP CARE C, 8(5), 2000, pp. 423-426

Authors: Tsai, CM Chang, KT Li, L Perng, RP Yang, LY
Citation: Cm. Tsai et al., Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression, and epidermal growth factor receptor level in non-small cell lung cancer cells, JPN J CANC, 91(2), 2000, pp. 213-222

Authors: Perng, RP Shih, JF Chen, YM Chou, KC Lee, YC Tsai, CM
Citation: Rp. Perng et al., A phase II study of single-agent docetaxel chemotherapy for nonsmall cell lung cancer, JPN J CLIN, 30(10), 2000, pp. 429-434

Authors: Chen, YM Perng, RP Yang, KY Lin, WC Wu, HW Liu, JM Tsai, CM Whang-Peng, J
Citation: Ym. Chen et al., A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer, AM J CL ONC, 23(1), 2000, pp. 13-17

Authors: Perng, RP Shih, JF Chen, YM Delgado, FM Tsai, CM Chou, KC Liu, JM Chern, MS Whang-Peng, J
Citation: Rp. Perng et al., A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer, AM J CL ONC, 23(1), 2000, pp. 60-64

Authors: Chen, YM Perng, RP Whang-Peng, J Wu, HW Lin, WC Tsai, CM
Citation: Ym. Chen et al., Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer, LUNG CANC, 30(3), 2000, pp. 199-202

Authors: Chen, YM Perng, RP Yang, KY Lin, WC Wu, HW Tsai, CM Whang-Peng, J
Citation: Ym. Chen et al., Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy, LUNG CANC, 29(2), 2000, pp. 139-146

Authors: Liu, YY Chen, YM Huang, MH Perng, RP
Citation: Yy. Liu et al., Prognosis and recurrent patterns in bronchioloalveolar carcinoma, CHEST, 118(4), 2000, pp. 940-947

Authors: Wang, PC Yang, KY Chao, JY Liu, JM Perng, RP Yen, SH
Citation: Pc. Wang et al., Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer, CHEST, 118(3), 2000, pp. 744-749

Authors: Chen, YM Perng, RP Yang, KY Liu, TW Tsai, CM Ming-Liu, J Whang-Peng, J
Citation: Ym. Chen et al., A multicenter phase II trial of vinorelbine plus gemcitabine in previouslyuntreated inoperable (stage IIIB/IV) non-small cell lung cancer, CHEST, 117(6), 2000, pp. 1583-1589

Authors: Kuo, CW Chen, YM Chao, JY Tsai, CM Perng, RP
Citation: Cw. Kuo et al., Non-small cell lung cancer in very young and very old patients, CHEST, 117(2), 2000, pp. 354-357

Authors: Lam, AWC Chen, YM Yang, KY Tsai, CM Perng, RP
Citation: Awc. Lam et al., Disconnection of a venous Port-A-Cath followed by embolization after saline flush: Rare case report, JPN J CLIN, 29(12), 1999, pp. 643-645

Authors: Kuo, CW Lee, YC Perng, RP
Citation: Cw. Kuo et al., Tracheal bronchus associated with lung cancer - A case report, CHEST, 116(4), 1999, pp. 1125-1127

Authors: Lee, YC Chern, JH Pan, CC Chang, SC Perng, RP
Citation: Yc. Lee et al., Argyrophilic nucleolar organizer regions in cells of thymoma and thymic carcinoma - Correlation with DNA ploidy and clinicopathologic characteristics, CHEST, 115(4), 1999, pp. 1115-1119

Authors: Lai, CL Tsai, CM Tsai, TT Kuo, BIT Chang, KT Fu, HT Perng, RP Chen, JY
Citation: Cl. Lai et al., Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients, CLIN CANC R, 4(12), 1998, pp. 3025-3030

Authors: Lee, YC Chern, JH Lai, SL Perng, RP
Citation: Yc. Lee et al., Sialyl stage-specific embryonic antigen-1 - A useful marker for differentiating the etiology of pleural effusion, CHEST, 114(6), 1998, pp. 1542-1545
Risultati: 1-24 |